DISEASE DIAGNOSIS, DRUG DEVELOPMENT FOCUS
OF UH PROF’S BIOCHIP RESEARCH
B. Montgomery Pettitt One of Only Three Americans
to Present at International Nanoscience Conference
HOUSTON, Sept. 1, 2004 – Leading the way to disease diagnosis
and drug development, biochip research at the University of Houston
will be presented to an international audience of top nanoscientists
next week.
B. Montgomery Pettitt, the Hugh Roy and Lillie Cranz Cullen Distinguished
Professor of Chemistry at the University of Houston, has been selected
as one of the plenary speakers at the Pacific Rim Nanoscience Conference
Sept. 7-11 in Broome, Western Australia. Pettitt is one of only
three American scientists among the 21 invited speakers.
“The biochip industry is a new and nearly billion-dollar industry
and is ready to grow 10- to 100-fold very shortly,” Pettitt
said. “Biochips are a reality now, but they are still crude.
At the University of Houston, we have uncovered important design
principles for the next generation of biochips.”
The research in Pettitt’s lab is directed toward understanding
the fundamental principles of how hard surfaces affect softer biological
components like proteins and DNA. DNA chips, a type of biochip,
have DNA molecules attached to a high-tech chip surface and have
applications in genetic screening, disease diagnosis and drug development.
“The design of biochips depends critically on our understanding
of how biological molecules interact with high-tech materials,”
Pettitt said. “The conference provides an opportunity for
the materials science and biotech communities of the world to come
together. And the proximity to Asia means that many members of that
community will attend and mix with Europeans and Americans.”
During the “Nanodevices” portion of the symposium,
as part of session two on “Nanobio Interfaces,” Pettitt’s
talk – “Poly-electrolytes at the liquid solid interface:
Biochips” – will begin at 4:30 p.m., Tuesday, Sept.
7, in the Sam Male North, Cable Beach Resort.
Starting during the conference week and continuing through the
month, all lectures (including slides and audio) from the conference
will be available through http://nanotech.colayer.net/
for those unable to physically attend the conference in Australia.
This virtual version of the conference also will provide Internet
participants an opportunity to post questions and discussion items.
Nanoscience is strongly multidisciplinary, and the conference will
reflect this diversity with contributions from physics, chemistry,
biology and engineering. The conference will provide a forum for
jumpstarting international collaborations. In addition to the U.S.,
speakers will come from Australia, Japan, China and Europe.
The principal aims of the conference are to bring together the
leading academic and industrial researchers in the experimental
and theoretical nanosciences, to showcase the role of computational
science underpinning and enabling innovations, and to consider specific
applications of nanotechnology. Conference proceedings will be published
in the international journal, Molecular Simulation.
About the University of Houston
The University of Houston, Texas’ premier metropolitan research
and teaching institution, is home to more than 40 research centers
and institutes and sponsors more than 300 partnerships with corporate,
civic and governmental entities. UH, the most diverse research university
in the country, stands at the forefront of education, research and
service with more than 35,000 students.
For more information about the Pacific Rim Nanoscience Conference,
visit http://physchem.ch.ic.ac.uk/broome/.
For more information on BioNano Technology at UH, visit http://www.uh.edu/bionano.
To receive UH science news via e-mail, visit www.uh.edu/admin/media/sciencelist.html.
For more information about UH visit the universitys Newsroom at www.uh.edu/admin/media/newsroom.
|